These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8345529)

  • 1. Purification and crystallization of Shiga toxin from Shigella dysenteriae.
    Kozlov YV; Chernaia MM; Fraser ME; James MN
    J Mol Biol; 1993 Jul; 232(2):704-6. PubMed ID: 8345529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution.
    Fraser ME; Chernaia MM; Kozlov YV; James MN
    Nat Struct Biol; 1994 Jan; 1(1):59-64. PubMed ID: 7656009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga toxin: purification, structure, and function.
    Donohue-Rolfe A; Acheson DW; Keusch GT
    Rev Infect Dis; 1991; 13 Suppl 4():S293-7. PubMed ID: 2047652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and analysis of crystal forms of toxic shock syndrome toxin 1.
    Earhart CA; Prasad GS; Murray DL; Novick RP; Schlievert PM; Ohlendorf DH
    Proteins; 1993 Nov; 17(3):329-34. PubMed ID: 8272430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of subunit B of Shiga toxin using a synthetic trisaccharide-based affinity matrix.
    Pozsgay V; Trinh L; Shiloach J; Robbins JB; Donohue-Rolfe A; Calderwood SB
    Bioconjug Chem; 1996; 7(1):45-55. PubMed ID: 8741990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insertion and orientation of a synthetic peptide representing the C-terminus of the A1 domain of Shiga toxin into phospholipid membranes.
    Saleh MT; Ferguson J; Boggs JM; Gariépy J
    Biochemistry; 1996 Jul; 35(29):9325-34. PubMed ID: 8755710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin.
    Noda M; Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
    Microb Pathog; 1987 May; 2(5):339-49. PubMed ID: 3148810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of purified Shiga toxin from Shigella dysenteriae 1.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization of A and B subunits of Shiga toxin and reconstitution of holotoxin from isolated subunits.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1987; 31(3):189-97. PubMed ID: 3302622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
    Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
    J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level expression of Shiga toxin B subunit of Shigella dysenteriae serotype 1 in Escherichia coli.
    Su G; Li F; Huang P; Rui X; Huang C
    Chin J Biotechnol; 1993; 9(1):49-55. PubMed ID: 8155839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallization and preliminary X-ray analysis of a microbial superantigen staphylococcal enterotoxin C2.
    Passalacqua EF; Brehm RD; Acharya KR; Tranter HS
    J Mol Biol; 1993 Sep; 233(1):170-2. PubMed ID: 8377185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit.
    Calderwood SB; Acheson DW; Goldberg MB; Boyko SA; Donohue-Rolfe A
    Infect Immun; 1990 Sep; 58(9):2977-82. PubMed ID: 2201641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of functional Shiga toxin subunits and renatured holotoxin.
    Donohue-Rolfe A; Jacewicz M; Keusch GT
    Mol Microbiol; 1989 Sep; 3(9):1231-6. PubMed ID: 2677606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of a lethal toxin produced by Shigella dysenteriae.
    Okamoto K; Takeda Y; Miwatani T
    Toxicon; 1982; 20(2):451-6. PubMed ID: 7043787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallization and preliminary X-ray characterization of tobacco streak virus and a proteolytically modified form of the capsid protein.
    Sehnke PC; Johnson JE
    Virology; 1993 Sep; 196(1):328-31. PubMed ID: 8356802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification, circular dichroism analysis, crystallization and preliminary X-ray diffraction analysis of the F plasmid CcdB killer protein.
    Steyaert J; Van Melderen L; Bernard P; Thi MH; Loris R; Wyns L; Couturier M
    J Mol Biol; 1993 May; 231(2):513-5. PubMed ID: 8389886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.
    Brown JE; Griffin DE; Rothman SW; Doctor BP
    Infect Immun; 1982 Jun; 36(3):996-1005. PubMed ID: 7047403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification, crystallization and preliminary X-ray analysis of toxic shock syndrome toxin-1 from Staphylococcus aureus.
    Passalacqua EF; Brehm RD; Acharya KR; Tranter HS
    J Mol Biol; 1992 Dec; 228(3):983-6. PubMed ID: 1469731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallization of the mosquito-larvicidal binary toxin produced by Bacillus sphaericus.
    Smith AW; Camara-Artigas A; Allen JP
    Acta Crystallogr D Biol Crystallogr; 2004 May; 60(Pt 5):952-3. PubMed ID: 15103150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.